Current Indications for Transcatheter Edge-to-Edge Repair in a Patient With Primary Mitral Regurgitation
Rebecca T Hahn, Vincent Chan, David H Adams
Surgical mitral valve repair for primary (degenerative) mitral regurgitation (MR) is associated with very low operative mortality and excellent long-term survival rates; it is a class I treatment option for symptomatic or asymptomatic patients in whom a successful (MR grade ≤1+), durable repair is possible.1 Mitral valve surgery is associated with a high rate of successful repair of simple to complex pathologies by using a variety of surgical techniques.2 The emergence of mitral transcatheter edge-to-edge repair (TEER) offers a new paradigm for the treatment of primary MR in a select group of patients, and is currently a class IIa treatment option for high- or prohibitive-risk patients with a life expectancy of at least 1 year.1 Given the current guideline indications, how should clinicians determine the appropriate patient for transcatheter intervention today?
Share
Publications
-
Transcatheter Repair for Patients with Tricuspid Regurgitation
Paul Sorajja, MD, Brian Whisenant, MD, David H. Adams, MD, et al. -
Failure to Rescue: A Quality Metric for Cardiac Surgery and Cardiovascular Critical Care
Caroline R Gross, David H Adams, Parth Patel, Robin Varghese -
Research Opportunities in the Treatment of Mitral Valve Prolapse: JACC Expert Panel
Francesca N Delling, Peter A Noseworthy, David H Adams, et al. -
Plasma Renin Activity Increases With Cardiopulmonary Bypass and is Associated With Vasoplegia After Cardiac Surgery
Morgan L Montgomery, Caroline R Gross, Hung-Mo Lin, Yuxia Ouyang, Matthew A Levin, Holly E Corkill, Ahmed El-Eshmawi, David H Adams, Menachem M Weiner